Cuprina Holdings Inc (CUPR)
Cuprina Holdings Inc is a common stock listing on NASDAQ tied to a biomedical and biotechnology company focused on chronic wound care. Through its subsidiary structure, the company develops and commercializes products for wound management, including MEDIFLY-branded sterile blowfly larvae bio-dressing products used for biological debridement. Its development pipeline also includes collagen-based dressings such as sponges, particles, and hydrogels made with bullfrog collagen derived from abattoir waste valorization, as well as medical leech-based products for wound treatment. Cuprina was founded in 2019 and is based in Singapore.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CUPR
|
$1.30
|
-26.3% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
April 27, 2027
|
3.1x
|
317.6x
|
12.397 M
|
12.489 M
|
16.6%
|
74.9%
|
0.7
|
196.7%
|
